bpc-157 safety concerns fda What to Know About Peptides the Is Considering for Use BPC-157 Legal Status: FDA Regulations

If a patient is already suffering from an undiagnosed vitamin B12 deficiency, correcting that deficit via a compounded injection will undoubtedly improve their overall well-being, resolve their anemia, and restore their baseline energy levels

The MHRA-approved hydroxocobalamin formulation is the preferred injectable form in the UK, as it has a longer duration of action compared to cyanocobalamin

Standard maintenance therapy typically involves hydroxocobalamin 1mg injections every two to three months for patients without neurological involvement

However, these are population averages your optimal dose depends on your CYP enzyme metabolism, body weight, injury severity, and whether you're stacking with other peptides